MAP2K7 and Miyoshi myopathy: Thus, in this review we will focus on the RAS/RAF/MEK/ERK signaling pathway and the role of the anti-apoptotic protein BCL-2, both of whom are engaged in the pathogenesis of MM and discuss the implementation of related targeting therapies.